Drug intelligence / Profile preview

gadolinium (Bayer)

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous
01

Overview

Gadolinium is a paramagnetic contrast agent primarily used in magnetic resonance imaging (MRI) to enhance the visibility of internal body structures. In the specific context of the clinical trial led by Li Nguyen for cervical dystonia, gadolinium is utilized as a tracer to evaluate the distribution, localization, and persistence of fluids injected into the tissue. The study compares the delivery of injections via the ASIS (Automated Subdermal Injection System) device, which targets the subdermal space and fascia, against traditional intramuscular injections. By measuring the persistent percentage of gadolinium on MRI at 6, 12, and 24 hours, the trial aims to demonstrate that subdermal delivery can prolong the presence of therapeutic agents like onabotulinumtoxinA (Botox) at the site of action while minimizing systemic spread and adverse reactions.

Brand names
MagnevistGadavistDotaremOmniscanProHanceMultiHanceAblavarEovist
Other names
gadolinium contrast mediumgadolinium-based contrast agentGBCA

Beyond the preview

Go deeper on gadolinium (Bayer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gadolinium (Bayer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call